ironomycin

N/A

Report date: 2025/03/20 15:11:22
NME

Base Information

Drug Nameironomycin
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIron metabolism modulators
TargetsUpdating
Therapy Area/IndicationsNeoplasm MetastasisLeukemia, Myeloid, AcuteNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInstitut Curie
China Registration ClassN/A

Develop Information

Active CompaniesSideROSInstitut Curie
Inactive CompaniesN/A
Active IndicationsNeoplasm MetastasisLeukemia, Myeloid, Acute
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A